201. [Macrophage inflammatory protein-1α promotes the growth of acute myeloid leukemia cells].
- Author
-
Lu P, Wang YJ, Zheng YW, Dong F, Pang YK, Cheng H, Yuan WP, Cheng T, and Hao S
- Subjects
- Animals, Cell Line, Tumor, Cell Proliferation, Chemokine CCL3, Chemokine CCL4, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Macrophage Inflammatory Proteins, Mice, Multiple Myeloma, Receptors, CCR1, Leukemia, Myeloid, Acute
- Abstract
Unlabelled: BACKGROWND: Macrophage inflammatory protein-1α (MIP-l α/CCL3) belongs to the C-C chemokine family (CCL3), which can be secreted by macrophages, other types of hematopoietic cells and bone marrow stromal cells. Higher levels of MIP-1α were found to be associated with several kinds of hematologic malignancies, including multiple myeloma (MM), chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML). Moreover, MIP-1α has been reported to be an adverse prognostic factor for CLL. However, the impact of MIP-1α on acute myeloid leukemia (AML) has been poorly investigated., Objective: To investigate the influence of MIP-1α on proliferction of AML cells., Methods: Using MLL-AF9 induced AML mouse model, the expression of MIP-1α was measured by real time quantitative RT-PCR. AML cell proliferation was examined by cell counting and colony forming assay (CFC). The influence of blocking the MIP-1α action on the growth and pathogenic ability of AML cells was explored by using the small molecule antagonist for interfering interaction of MIP-1α with its receptor CCR1., Results: The MIP-1α could promote the proliferation and colony formation of AML cells, the blocking MIP-1a could inhibit the growth of AML cells and delay onset of AML., Conclusion: The MIP-1a promotes the occurence and progression of AML, therefore blocking the MIP-1α signal pathway may be served as a strategy to inhibit the growth of AML cells, and MIP-1α can be a potential target for treatment of AML.
- Published
- 2015
- Full Text
- View/download PDF